Strength
50 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603055602
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204028On Market Since
5/2/2025
Pharmacological Classes
Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor
Related Drugs
Same classification
CITALOPRAM HBR 10 MG TABLET
Generic
00378623101•Mylan Pharmaceuticals Inc.
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
00378623105•Mylan Pharmaceuticals Inc.
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
00904608461•Major Pharmaceuticals
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
13668000901•Torrent Pharmaceuticals Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
13668000905•Torrent Pharmaceuticals Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
13668000909•Torrent Pharmaceuticals Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
42806001901•Epic Pharma LLC
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
42806001910•Epic Pharma LLC
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
65862000501•Aurobindo Pharma Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
65862000505•Aurobindo Pharma Limited
$0.0254
per EA